Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 26, 143-148, January 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taper, H. S.
Right arrow Articles by Lardis, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taper, H. S.
Right arrow Articles by Lardis, M. P.

A New Transplantable Mouse Liver Tumor of Spontaneous Origin1

Henryk S. Taper2, George W. Woolley, Morris N. Teller and Michael P. Lardis

Division of Experimental Chemotherapy and Division of Special Studies, Sloan-Kettering Institute for Cancer Research, and Sloan-Kettering Division, Graduate School of Medical Sciences, Cornell University Medical College, New York, New York

A transplantable primary liver tumor 1st observed in a 2-month-old female Swiss-Webster mouse is described. Morphologically, it was poorly differentiated. It was easily converted into an ascitic form. The tumor grew rapidly and uniformly without regression in 100% of Swiss-Webster mice after the 2nd transplant generation. Several characteristics of this tumor distinguish it from other transplantable primary liver tumors of the mouse; growth was rapid and invasive, and by Generation 4 no host-conditioning (X-irradiation and/or cortisone) was required; strain specificity was minimal, with progressive tumor growth in 100% of C3HeB/FeJ, DBA/2J, C57BL/6 Millerton, AKR/J, and C56BR/cdJ inbred, and in ICR/Ha Swiss random-bred mice.

1 This study was supported in part by Research Grant CY-3784 from the National Cancer Institute, USPHS, Bethesda, Maryland.

2 International Postdoctoral Research Fellow, U. S. Department of Health, Education and Welfare, Public Health Service, Bethesda, Maryland. Present address: Department of Pathological Anatomy, Catholic University, Voer des Capucins 37, Louvain, Belgium.

Received 3/23/65. Revised 7/29/65.


This article has been cited by other articles:


Home page
Cancer Res.Home page
P. Martinive, F. Defresne, C. Bouzin, J. Saliez, F. Lair, V. Gregoire, C. Michiels, C. Dessy, and O. Feron
Preconditioning of the Tumor Vasculature and Tumor Cells by Intermittent Hypoxia: Implications for Anticancer Therapies
Cancer Res., December 15, 2006; 66(24): 11736 - 11744.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Ansiaux, C. Baudelet, B. F. Jordan, N. Crokart, P. Martinive, J. DeWever, V. Gregoire, O. Feron, and B. Gallez
Mechanism of Reoxygenation after Antiangiogenic Therapy Using SU5416 and Its Importance for Guiding Combined Antitumor Therapy
Cancer Res., October 1, 2006; 66(19): 9698 - 9704.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
P. Martinive, J. De Wever, C. Bouzin, C. Baudelet, P. Sonveaux, V. Gregoire, B. Gallez, and O. Feron
Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable variable to improve drug delivery.
Mol. Cancer Ther., June 1, 2006; 5(6): 1620 - 1627.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Ansiaux, C. Baudelet, G. O. Cron, J. Segers, C. Dessy, P. Martinive, J. De Wever, J. Verrax, V. Wauthier, N. Beghein, et al.
Botulinum Toxin Potentiates Cancer Radiotherapy and Chemotherapy
Clin. Cancer Res., February 15, 2006; 12(4): 1276 - 1283.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Sonveaux, C. Dessy, P. Martinive, X. Havaux, B. F. Jordan, B. Gallez, V. Gregoire, J.-L. Balligand, and O. Feron
Endothelin-1 Is a Critical Mediator of Myogenic Tone in Tumor Arterioles: Implications for Cancer Treatment
Cancer Res., May 1, 2004; 64(9): 3209 - 3214.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Sonveaux, A. Brouet, X. Havaux, V. Gregoire, C. Dessy, J.-L. Balligand, and O. Feron
Irradiation-induced Angiogenesis through the Up-Regulation of the Nitric Oxide Pathway: Implications for Tumor Radiotherapy
Cancer Res., March 1, 2003; 63(5): 1012 - 1019.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. F. Jordan, V. Gregoire, R. J. Demeure, P. Sonveaux, O. Feron, J. O'Hara, V. P. Vanhulle, N. Delzenne, and B. Gallez
Insulin Increases the Sensitivity of Tumors to Irradiation: Involvement of an Increase in Tumor Oxygenation Mediated by a Nitric Oxide-dependent Decrease of the Tumor Cells Oxygen Consumption
Cancer Res., June 1, 2002; 62(12): 3555 - 3561.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. S. Taper and M. Roberfroid
Influence of Inulin and Oligofructose on Breast Cancer and Tumor Growth
J. Nutr., July 1, 1999; 129(7): 1488 - 1488.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1966 by the American Association for Cancer Research.